EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

From Precision to Personalized: Catalyzing AI ‐Enabled Innovation in Drug Development

Adarsh Subbaswamy iD, Allison Dunn iD, Brooke Langevin iD, Sooyoung Lee iD, Mathangi Gopalakrishnan iD, Jogarao V S Gobburu iD

Clinical and Translational Science · 2026-06 · 19 (6)

DOI: 10.1111/cts.70617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 19.05.2026. Verfasst von Adarsh Subbaswamy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Medicine, University of Maryland School of Pharmacy, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Precision Medicine, Drug Development, Artificial Intelligence. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In 2015, President Obama announced the Precision Medicine Initiative in his nationally televised State of the Union address. The vision was bold: to enable a new era of medicine through research, technology, and policies that empower patients, researchers, and providers to work together toward the development of individualized care. Now, more than 10 years later, how have the treatments available to patients changed?

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineDrug DevelopmentArtificial IntelligenceHumansUnited States

Stichwörter der Autor:innen

artificial intelligencedrug developmentpersonalized medicineprecision medicineregulatory science

Autor:innen und Institutionen

  • Center for Translational Medicine, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.

ORCID-Profile: Adarsh Subbaswamy, Allison Dunn, Brooke Langevin, Sooyoung Lee, Mathangi Gopalakrishnan, Jogarao V S Gobburu

Zitieren

APA

Subbaswamy, A., Dunn, A., Langevin, B., Lee, S., Gopalakrishnan, M., & Gobburu, J. V. S. (2026). From Precision to Personalized: Catalyzing AI ‐Enabled Innovation in Drug Development. Clinical and Translational Science, 19(6). https://doi.org/10.1111/cts.70617

Vancouver

Subbaswamy A, Dunn A, Langevin B, Lee S, Gopalakrishnan M, Gobburu JVS. From Precision to Personalized: Catalyzing AI ‐Enabled Innovation in Drug Development. Clinical and Translational Science. 2026;19(6). doi:10.1111/cts.70617

BibTeX
@article{Subbaswamy2026,
  author = {Subbaswamy, Adarsh and Dunn, Allison and Langevin, Brooke and Lee, Sooyoung and Gopalakrishnan, Mathangi and Gobburu, Jogarao V S},
  title = {From Precision to Personalized: Catalyzing AI ‐Enabled Innovation in Drug Development},
  journal = {Clinical and Translational Science},
  year = {2026},
  volume = {19},
  number = {6},
  doi = {10.1111/cts.70617}
}
Kostenlos starten →